Swiss Life Asset Management’s Itron ITRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.2M Buy
163,747
+9,266
+6% +$791K 0.06% 244
2026
Q1
$13.8M Buy
154,481
+42,709
+38% +$4.1M 0.07% 225
2025
Q4
$10.4M Hold
111,772
0.05% 259
2025
Q3
$13.9M Buy
111,772
+874
+0.8% +$111K 0.07% 208
2025
Q2
$14.6M Buy
110,898
+12,643
+13% +$1.43M 0.09% 181
2025
Q1
$10.3M Buy
98,255
+778
+0.8% +$81.5K 0.07% 203
2024
Q4
$10.6M Buy
97,477
+2,079
+2% +$232K 0.08% 188
2024
Q3
$10.2M Buy
95,398
+3,517
+4% +$356K 0.12% 170
2024
Q2
$9.09M Buy
+91,881
New +$9.25M 0.11% 172
2022
Q4
Sell
-7,370
Closed -$310K 613
2022
Q3
$310K Buy
7,370
+1,132
+18% +$56.4K 0.01% 552
2022
Q2
$309K Buy
+6,238
New +$309K 0.01% 562

Other funds holding ITRI

Swiss Life Asset Management's ITRI Position: Q2 2026 in Review

Swiss Life Asset Management increased its Itron (ITRI) stake by 6% in Q2 2026, buying an estimated $791K and bringing the position to 163,747 shares worth $14.2M. The position accounts for 0.06% of the portfolio, ranked #244.

Swiss Life Asset Management first reported a position in ITRI in Q2 2022 and has held it in 11 quarters since. The position peaked at $14.6M in Q2 2025. 242 funds tracked by Wall St. Rank hold ITRI as of Q2 2026.

  • Swiss Life Asset Management held 163,747 shares of Itron worth $14.2M as of Q2 2026.
  • Swiss Life Asset Management bought 9,266 Itron shares in Q2 2026, an estimated $791K.
  • Itron made up 0.06% of Swiss Life Asset Management's portfolio in Q2 2026, its #244 holding.
  • Swiss Life Asset Management first reported a position in Itron in Q2 2022 and has held it in 11 quarters since.
  • Swiss Life Asset Management's Itron position peaked at $14.6M in Q2 2025.
  • 242 funds tracked by Wall St. Rank held Itron as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.